[e-drug] Continuing Professional Development: international Perspective

[fumken@yahoo.co.uk]

E-DRUG: Continuing Professional Development: international Perspective
----------------------------------------------------------------------

Dear all, 

I am undertaking a project on Continuing Professional Development. I will
appreciate it very much if you can help me by filling the questionnaire
below and returning to me.

Thanks for your cooperation.

Mrs Funmi O M Oduniyi (MRPharmS, MPSN, MBA) 

*******************

  CPD An international Perspective

    1.. Is CPD mandatory for your profession in your country..Yes/No 

    2.. How long has it been on-going?  1.  less than 3 years 2. 3-7 years
3. over 7-10 years 4) over 10 yrs 

    3.. Has it always been mandatory? Yes/ No 

    4.. What is the mode of learning- taught/ distance learning/ other
(please specify)..........................

   4b) Please elaborate.............................................
 
...................................................................

    5.. Which is the formal body responsible for organization, monitoring
and evaluation? (if applicable, kindly give a contact e-mail or web-site)

    6.. What is the mode of enforcement (if mandatory) or motivation (if
voluntary)?

    7.. What is your own opinion of the outcome-  Very successful/ Fairly
successful / Undecided/ Not working

    8.. Your country............................ 

    9.. Age-  less than 25  /   25 to 35 / 36 to 45 /   46-55 / 55-65 / Over
65 

    10.. Gender: Male/ Female

    11.. Your discipline - Medicine/ Nursing/ Pharmacy/ Other (Please
Specify).........................................

    12.. Any other comments?

  Thank you.

--
Funmi Oduniyi
Clinical Pharmacist
Nigeria
[details added by moderator]
fumken@yahoo.co.uk

[Please send all responses directly to Funmi Oduniyi at fumken@yahoo.co.uk
Do NOT use the REPLY button as then your message goes back to the E-drug
moderator. Make a new, separate email or FORWARD the e-drug message to
Funmi. Thanks! Wilbert Bannenberg, co-moderator; e-drug-owner@healthnet.org]